Pfizer Offered $99 Billion In AstraZeneca Bid - Presented by: The Aol. On Network

Pfizer confirmed today that it had asked AstraZeneca to consider a merger, and been rebuffed. Under U.K. law, it had to disclose the offer and went public with a $98.7 billion offer to buy the London-based drug maker. The deal will be 70% cash and 30% stock, and will provide Pfizer with a way to use funds it has kept out of the U.S. without paying U.S. taxes. The deal would also allow Pfizer to lower its tax rate by creating a holding company in the U.K.



Related Videos

Most Popular Videos

Latest Videos

LG G4 Android Review
LG G4 Android Review                
Toothbrush Tech
Toothbrush Tech                     

Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 132.815 1.43 ▲ 1.08%
BAC $ 16.79 0.06 ▲ 0.36%
ONTY $ 2.93 0.42 ▲ 16.73%
HPQ $ 34.95 1.12 ▲ 3.31%
PBMD $ 3.5166 0.47 ▲ 15.30%
PBR $ 9.1445 0.35 ▼ 3.64%
BABA $ 93.7633 0.12 ▼ 0.12%
AVEO $ 2.20 0.03 ▼ 1.35%

As of 5/22/2015, 01:41 PM